alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles.

Van Kaer L
Nat Rev Immunol. 2005 5 (1): 31-42

PMID: 15630427 · DOI:10.1038/nri1531

MeSH Terms (8)

Animals Autoimmune Diseases Autoimmunity Galactosylceramides Humans Immunologic Factors Killer Cells, Natural T-Lymphocyte Subsets

Connections (1)

This publication is referenced by other Labnodes entities:

Links